New estimates of diabetes occurrence in Norway
/In September 2026, the Norwegian Institute of Public Health published updated figures on diabetes occurrence in Norway, based on national administrative registries. It was estimated that, in 2025, about 0.64% of people in Norway across all ages were living with type 1 diabetes, while 4.8% had been diagnosed with type 2 diabetes. Previous estimates based on older and external data found that around 20% of people with type 2 diabetes had not yet been diagnosed - these figures were unchanged, but the absolute number was updated. Altogether, an estimated 375 000 people in Norway were living with diabetes in 2025, indicating an increase in recent years. This may be partly because more people develop diabetes, but data on incidence of type 2 diabetes has stabilized in the past decade and the increasing prevalence may reflect improved longevity among people with diabetes as well as the fact that every year, there are more new cases of people diagnosed with diabetes than there are people with diabetes who die.
The new figures also indicate an increase in the number of people using glucose-lowering medication, to 255 000 people in 2025. While some newer glucose lowering medications (SGLT-2 inhibitors and GLP-1 receptor agonists) are also used for indications other than diabetes, the data in the report were restricted to those with diabetes as per reimbursement code. Also, while the figures may partly reflect an increasing proportion of patients with type 2 diabetes being treated with glucose lowering medication, this was not apparent in the available registry data.
The full chapter on diabetes in the 2026 Public Health Report from the Norwegian Institute of Public Health can be accessed here: https://www.fhi.no/he/fr/folkehelserapporten/ikke-smittsomme/diabetes/ (the report is available in Norwegian).
Although diabetes affects many people in Norway, there is reason for hope. Better awareness, earlier diagnosis, and advances in treatment mean that more people can live well with diabetes. At Oslo Diabetes Research Centre, we will continue our work to contribute to improved prevention and to help develop even better treatments in the future.
